These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9291697)

  • 21. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
    Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
    Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain.
    Yang CY; Wong CS; Chang JY; Ho ST
    Can J Anaesth; 1996 Apr; 43(4):379-83. PubMed ID: 8697554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous infusion of dexmedetomidine can prevent the degeneration of spinal ventral neurons induced by intrathecal morphine after a noninjurious interval of spinal cord ischemia in rats.
    Kakinohana M; Oshiro M; Saikawa S; Nakamura S; Higa T; Davison KJ; Marsala M; Sugahara K
    Anesth Analg; 2007 Oct; 105(4):1086-93, table of contents. PubMed ID: 17898393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal morphine therapy related granulomas: two case reports.
    Miele VJ; Price K; Bloomfield S; Hogg J; Bailes J
    W V Med J; 2006; 102(5):16-8. PubMed ID: 17285949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is anti-hyperalgesia clinically relevant? Dosage increase is hardly necessary].
    MMW Fortschr Med; 2006 Jan; 148(1-2):43. PubMed ID: 16610415
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of timing of systemic ketamine administration on postoperative morphine consumption.
    Bilgin H; Ozcan B; Bilgin T; Kerimoğlu B; Uçkunkaya N; Toker A; Alev T; Osma S
    J Clin Anesth; 2005 Dec; 17(8):592-7. PubMed ID: 16427528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
    Remérand F; Le Tendre C; Baud A; Couvret C; Pourrat X; Favard L; Laffon M; Fusciardi J
    Anesth Analg; 2009 Dec; 109(6):1963-71. PubMed ID: 19923527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion.
    Singla A; Stojanovic MP; Chen L; Mao J
    Anesth Analg; 2007 Dec; 105(6):1816-9, table of contents. PubMed ID: 18042887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in systemic morphine analgesic tolerance following intrathecal morphine injections.
    Hopkins E; Rossi G; Kest B
    Brain Res; 2004 Jul; 1014(1-2):244-6. PubMed ID: 15213009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative continuous intrathecal pain treatment in children after selective dorsal rhizotomy with bupivacaine and two different morphine doses.
    Hesselgard K; Strömblad LG; Romner B; Reinstrup P
    Paediatr Anaesth; 2006 Apr; 16(4):436-43. PubMed ID: 16618299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributions of spinal D-amino acid oxidase to chronic morphine-induced hyperalgesia.
    Ma S; Li XY; Gong N; Wang YX
    J Pharm Biomed Anal; 2015 Dec; 116():131-8. PubMed ID: 25850373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of ketamine infusion to dramatically reduce opioid requirements in a patient whose high-dose intrathecal opioid pump was inadvertently cut during surgery.
    McDonald WM; Wilkinson MM; Jain A; Cohen SP
    Pain Pract; 2023 Nov; 23(8):978-981. PubMed ID: 37312629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid-induced hyperalgesia: low-dose ketamine does work for some orthopaedic problems already.
    Griffiths R
    Br J Anaesth; 2010 May; 104(5):660-1; author reply 661. PubMed ID: 20400615
    [No Abstract]   [Full Text] [Related]  

  • 36. Histological findings after long-term infusion of intrathecal ketamine for chronic pain: a case report.
    Stotz M; Oehen HP; Gerber H
    J Pain Symptom Manage; 1999 Sep; 18(3):223-8. PubMed ID: 10517045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short- and long-term efficacy of oral ketamine in eight chronic-pain patients.
    Furuhashi-Yonaha A; Iida H; Asano T; Takeda T; Dohi S
    Can J Anaesth; 2002 Oct; 49(8):886-7. PubMed ID: 12374726
    [No Abstract]   [Full Text] [Related]  

  • 38. Burst ketamine to reverse opioid tolerance in cancer pain.
    Mercadante S; Villari P; Ferrera P
    J Pain Symptom Manage; 2003 Apr; 25(4):302-5. PubMed ID: 12691680
    [No Abstract]   [Full Text] [Related]  

  • 39. Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation.
    Cairns J; Feng TL; Ong MC
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38176753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain.
    Willeford A; Atayee RS; Winters KD; Mesarwi P
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):248-255. PubMed ID: 31125279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.